Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60

By sjmartinez • April 23, 2024

Egeberg A, Hawkes JE, Somani N, Burge R, See K, Gallo G, McKean-Matthews M, Gooderham M, Han G, Armstrong A. Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60. Dermatol Ther (Heidelb). 2024 Apr 22. doi: 10.1007/s13555-024-01147-7. Epub ahead of print. PMID: 38647975.

Tags: Clinical outcomes, Dermatology, ixekizumab, long-term, patient-reported outcomes, psoriasis, Publications, Quality of Life, Scalp clearance

Genome-wide DNA methylation patterns in Daphnia magna are not significantly associated with age

Liu R, Morselli M, Yampolsky LY, Peshkin L, Pellegrini M. Genome-wide DNA methylation patterns in Daphnia magna are not significantly associated with age. Epigenetics Chromatin.[...]

Biological Aging in Combination with Lifestyle Factors in the Blood-Based Methylome: A Biomarker for Colorectal Cancer Susceptibility in African American Women

Jung SY, Pellegrini M, Yu H. Biological Aging in Combination with Lifestyle Factors in the Blood-Based Methylome: A Biomarker for Colorectal Cancer Susceptibility in African[...]

Treatment of Solar Lentigines: A Systematic Review of Clinical Trials

Mardani G, Nasiri MJ, Namazi N, Farshchian M, Abdollahimajd F. Treatment of Solar Lentigines: A Systematic Review of Clinical Trials. J Cosmet Dermatol. 2025 Apr;24(4):e70133.[...]